GSK plc American Depositary Shares (Each representing two Ordinary Shares) Earnings Dividend

GSK plc American Depositary Shares (Each representing two Ordinary Shares)’s revenue jumped 5.3% since last year same period to $8409Mn in the Q2 2026. On a quarterly growth basis, GSK plc American Depositary Shares (Each representing two Ordinary Shares) has generated 10.22% jump in its revenue since last 3-months.

GSK plc American Depositary Shares (Each representing two Ordinary Shares)’s net profit fell -69.85% since last year same period to $435Mn in the Q2 2026. On a quarterly growth basis, GSK plc American Depositary Shares (Each representing two Ordinary Shares) has generated -74.96% fall in its net profits since last 3-months.

GSK plc American Depositary Shares (Each representing two Ordinary Shares)’s net profit margin fell -71.37% since last year same period to 5.17% in the Q2 2026. On a quarterly growth basis, GSK plc American Depositary Shares (Each representing two Ordinary Shares) has generated -77.28% fall in its net profit margins since last 3-months.

GSK plc American Depositary Shares (Each representing two Ordinary Shares)’s earning per share (EPS) estimates for the current quarter stand at 1.27 - a 9.48% jump from last quarter’s estimates.

GSK plc American Depositary Shares (Each representing two Ordinary Shares)’s earning per share (EPS) estimates for the current year stand at 1.27.

GSK plc American Depositary Shares (Each representing two Ordinary Shares)’s earning per share (EPS) jumped 9.68% since last year same period to 1.36 in the Q2 2026. This indicates that the GSK plc American Depositary Shares (Each representing two Ordinary Shares) has generated 9.68% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

GSK plc American Depositary Shares (Each representing two Ordinary Shares) declared 0.44 dividend per share during the earnings announcement for Q2 2026.